Latest CNCE reports update at 2022-11-07: 2022-Q3 ∙ 2022-Q2 ∙ 2022-Q1
  1. Home
  2. Stock quotes
  3. Concert Pharmaceuticals
  4. Financial Ratios
  5. EV/EBITDA Ratio
Concert Pharmaceuticals logo
Concert Pharmaceuticals CNCE
$ 8.37 0.0%
mail-toReport an Error

Concert Pharmaceuticals EV/EBITDA Ratio 2011-2024 | CNCE

Annual EV/EBITDA Ratio Concert Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-0.193 -3.46 -2.61 -5.81 4.79 -3.14 9.01 -6.86 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
9.01 -6.86 -1.03